Treatment of hepatitis C virus infection: updated Swedish Consensus recommendations

Area of Science:

• Hepatology
• Infectious Diseases
• Virology

Background:

• Hepatitis C virus (HCV) infection remains a significant global health concern.
• Current treatment strategies require updated recommendations based on expert consensus.
• Co-infections and specific patient populations necessitate tailored therapeutic approaches.

Purpose of the Study:

• To present updated Swedish recommendations for HCV treatment.
• To outline vaccination strategies for patients with HCV.
• To define treatment protocols based on HCV genotype, viral response, and patient status.

Main Methods:

• Expert panel meeting to review and update treatment guidelines.
• Analysis of viral response metrics (vRVR, RVR, cEVR, pEVR) to guide treatment duration.
• Consideration of specific patient groups including those with HCV-HIV co-infection and liver transplant recipients.

Main Results:

• Hepatitis A and B vaccination is recommended for all HCV patients.
• Treatment initiation and duration are stratified by HCV genotype and viral kinetics.
• Specific recommendations are provided for symptomatic/asymptomatic acute HCV, difficult-to-treat cases, HCV-HIV co-infection, and liver transplant patients.

Conclusions:

• Updated guidelines provide a nuanced approach to HCV treatment, optimizing duration based on patient response.
• Vaccination against hepatitis A and B is a crucial preventive measure in HCV management.
• Tailored treatment strategies are essential for complex cases, including co-infections and post-transplant scenarios.